SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PawPr who wrote (99)5/12/1997 2:56:00 PM
From: Thean   of 965
 
Great news about CenTNF. I believe CenTNF is real money in the bucket for CNTO now. FDA would be unethical to not approve CenTNF for Crohn disease. When it is on the market for Crohn disease indication, CenTNF will become THE treatment very quickly and reducing the market share of all others much less effective ones in no time. Believe doctors will also try it on ulcerative colitis as a non-indication use. Wonder when pivotal study on ulcerative colitis will be carried out?

Check out:
biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext